5 questions on Abbott’s glucose-ketone sensors
As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.
MedTech industry news
Live Last read · last published · next check

Digital health technologies used in studies should be validated and measure outcomes that matter to patients, the FDA said.

The federal program aims to get stroke patients treated faster through autonomous mechanical thrombectomy. Several organizations will share up to $175.3 million in funding to develop robots.

Stryker, Medtronic and Abbott are among the collection of medical device firms that have disclosed cyberattacks this year. Check out MedTech Dive's roundup of coverage.

John Rogers, who has experience leading change at companies, is expected to help Baxter's turnaround gain traction. He joins Baxter after the company has spun out two business units.

The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist shortage.

Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.

The agency published a discussion paper this week as it considers the "unique risks" and potential promise of generative AI for patient care.

William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan's "no-nonsense" mindset on setting expectations a strength.
As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.

Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.
Sam Asgarian, Guardant Health's vice president of clinical development, discusses the progress and challenges of blood-based testing in colorectal and multicancer screening.

A third party may have accessed test results and Social Security numbers held by the genetic testing company.

Cadence, a company that makes AI-enabled software to support hypertension management, will join the pilot, which allows companies to collect real-world data through Medicare.